DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 1Olpha
03 32AstraZeneca
04 2Olon S.p.A
05 2TherDose Pharma
06 1XYZ Pharma
01 1CAPSULE;ORAL
02 1Capsule, hard
03 2Film Coated Tablet
04 2Filmtabl
05 1HARD CAPSULES
06 1Liquid-filled capsules
07 1Olaparib 50Mg 448 Unita' Oral Use
08 2Oral Solid Dosage Form
09 2TAB
10 2TABLET
11 2TABLET;ORAL
12 1Tablet
13 2Tablets
14 20Blank
01 1Available Dossier- US-EU-RoW
02 1DISCN
03 1Dossier Readiness:Q3 2026
04 2Lead Market Dossiers- Under Development
05 2Originator
06 2Prescription
07 2RX
08 29Blank
01 5LYNPARZA
02 25Lynparza
03 1Lynparza 100
04 1Lynparza 150
05 8Blank
01 1Argentina
02 20Australia
03 2Canada
04 4India
05 3Italy
06 1Latvia
07 1Norway
08 2South Africa
09 1Sweden
10 2Switzerland
11 3USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness:Q3 2026
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness:Q3 2026
Registration Country : Latvia
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LYNPARZA
Dosage Form : CAPSULE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2014-12-19
Application Number : 206162
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LYNPARZA
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2017-08-17
Application Number : 208558
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LYNPARZA
Dosage Form : TABLET;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date : 2017-08-17
Application Number : 208558
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Lynparza
Dosage Form : HARD CAPSULES
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Lynparza
Dosage Form : Olaparib 50Mg 448 Unita' Oral Use
Dosage Strength : 448 cps 50 mg vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Lynparza
Dosage Form : Capsule, hard
Dosage Strength : 50 mg
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Brand Name : Lynparza
Dosage Form : Filmtabl
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Lynparza
Dosage Form : Filmtabl
Dosage Strength : 150mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : LYNPARZA
Dosage Form : TABLET
Dosage Strength : 100MG
Packaging : 60/120
Approval Date :
Application Number : 2475200
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : LYNPARZA
Dosage Form : TABLET
Dosage Strength : 150MG
Packaging : 60/120
Approval Date :
Application Number : 2475219
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Lynparza 100
Dosage Form : TAB
Dosage Strength : 100mg
Packaging : 56X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Lynparza 150
Dosage Form : TAB
Dosage Strength : 150mg
Packaging : 56X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Available Dossier- US-EU-RoW
Registration Country : Italy
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Available Dossier- US-EU-RoW
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablets
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablets
Dosage Strength : 150mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Argentina
Brand Name :
Dosage Form : Liquid-filled capsules
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
LOOKING FOR A SUPPLIER?
